Company intelligence / Profile preview

Alliancells Biosciences

Suzhou, Jiangsu, China

Ownership: Private
Employees: ~60
Development stage: Other

Overview

Alliancells Biosciences is a biotechnology company specializing in the development of next-generation cell therapies, with a primary focus on induced pluripotent stem cell (iPSC) technology. The company aims to provide standardized, off-the-shelf cell products for treating degenerative diseases and other unmet medical needs. Their lead programs target neurological disorders, specifically Parkinson's disease, using iPSC-derived dopaminergic neurons. Alliancells operates out of Suzhou, China, and leverages advanced manufacturing platforms to ensure the scalability and safety of its therapeutic candidates.

Therapeutic areas: CardiovascularNeurology
Modalities: Cell therapyInduced pluripotent stem cell derived therapyStem cell therapy
Industry: Biotech

Beyond the preview

Go deeper on Alliancells Biosciences.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Alliancells Biosciences.

Explore the full profile